Molecular mobility in liquid and glassy states of Telmisartan (TEL) studied by Broadband Dielectric Spectroscopy

European Journal of Pharmaceutical Sciences

Volumn 38, Issue 4, 2009, Pages 395-404

  Adrjanowicz, K ^a   Wojnarowska, Z ^a   Wlodarczyk, P ^a   Kaminski, K ^a   Paluch, M ^a   Mazgalski, J ^b  

^a UNIVERSITY OF SILESIA   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Amorphous pharmaceuticals; Amorphous state; Broadband Dielectric Spectroscopy; Glass transition; Molecular mobility

Indexed keywords

TELMISARTAN;

ARTICLE; DRUG STABILITY; DRUG STORAGE; GLASS TRANSITION TEMPERATURE; MOLECULAR MECHANICS; PRIORITY JOURNAL; RELAXATION TIME; ROOM TEMPERATURE; SPECTROSCOPY; TEMPERATURE DEPENDENCE;

BENZIMIDAZOLES; BENZOATES; CHEMISTRY, PHARMACEUTICAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GLASS; SOLUBILITY; SPECTRUM ANALYSIS;

EID: 70349804230     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.09.009     Document Type: Article

References (70)

1. K. Adrjanowicz, K. Kaminski, M. Paluch, P. Wlodarczyk, K. Grzybowska, Z. Wojnarowska, et al., 2009a. Dielectric relaxation studies and dissolution behavior of amorphous verapamil hydrochloride, J. Pharm. Sci., doi:10.1002/jps.21877.
2. KWW-M = 0.51 form electric modulus representation. Taking into consideration the length of this paper and complexity of this issue we won't include the explanation of it here. However in the future we would like to discuss about this problem in a separate paper.
3. Alie J., Menegotto J., Cardon P., Duplaa H., Caron A., Lacabanne C., and Bauer M. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance. J. Pharm. Sci. 93 (2004) 218
4. Andronis V., and Zografi G. The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity. Pharm. Res. 15 (1998) 835-842
5. Angel C.A. Entropy and fragility of glass-forming liquids. J. Res. Natl. Inst. Technol. 102 (1997) 171
6. Angell C.A. Formation of glasses from liquids and biopolymers. Science 267 (1995) 1924
7. Antoncic, L., Copar, A., 2009. Preparation of Telmisartan salts with Improved solubility, Patent No. 20090012140.
8. 1HNMR relaxation time. J. Pharm. Sci. 89 3 (2000) 408-416
9. Bhugra C., and Pikal M. Role of thermodynamic, molecular, and kinetic factor in crystallization from amorphous state. J. Pharm. Sci. 97 (2007) 1329-1349
10. Bras A.R., Noronha J.P., Antunes A.M.M., Cardoso M.M., Schonhals A., Affouard F., Dionisio M., and Correia N.T. Molecular motions in amorphous Ibuprofen as studied by Broadband Dielectric Spectroscopy. J. Phys. Chem. B 112 35 (2008) 11087-11099
11. Carpentier L., Decressain R., Desprez S., and Descamps M. Dynamics of the amorphous and crystalline alpha-, gamma-phases of indomethacin. J. Phys. Chem. B 110 1 (2006) 457-464
12. Casalini R., and Roland C.M. Aging of the secondary relaxation to probe structural relaxation in the glassy state. Phys. Rev. Lett. 102 (2009) 035701
13. Casalini R., Ngai K.L., and Roland C.M. Connection between the high-frequency crossover of the temperature dependence of the relaxation time and the change of intermolecular coupling in glass-forming liquids. Phys. Rev. B 68 (2003) 014201
14. Corezzi S., Campani E., Rolla P.A., Capaccioli S., and Fioretto D. Changes in the dynamics of supercooled systems revealed by dielectric spectroscopy. J. Chem. Phys. 111 (1999) 9343
15. Craig D., Royall P., Kett V., and Hoptopn M. The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried system. Int. J. Pharm. 179 (1999) 179-207
16. Fujima T., Frusawa H., and Ito K. Merging of α and slow β relaxation in supercooled liquids. Phys. Rev. E 66 (2002) 031503
17. Fulcher G. Analysis of recent measurements of the viscosity of glasses. J. Am. Ceram. Soc. 8 6 (1925) 339-355
18. Gupta P., and Bansal A.K. Devitrification of amorphous celecoxib. AAPS PharmSciTech 6 2 (2005) Article 32
19. Gupta P., Chawla G., and Bansal A.K. Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility. Mol. Pharm. 1 6 (2004) 406-413
20. Hancock B.C., and Parks M. What is the true solubility advantage for amorphous pharmaceuticals?. Pharm. Res. 17 4 (2000)
21. Hancock B.C., and Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86 (1997) 1-12
22. Hancock B.C., Shamblin S.L., and Zografi G. The molecular mobility of amorphous pharmaceutical solid below their glass transition temperatures. Pharm. Res. 12 (1995) 799-806
23. Hatley R.H.M. Glass fragility and the stability of pharmaceutical preparations-excipient selection. Peharm. Delevop. Technol. 2 3 (1997) 257-264
24. Havriliak S., and Negami S. A complex plane representation of dielectric and mechanical relaxation processes in some polymers. Polymer 8 4 (1967) 161
25. Hikima T., Hanaya T., and Oguni M. β-Molecular rearrangement process, but not an α-process, as governing the homogeneous crystal-nucleation rate in a supercooled liquid. Bull. Chem. Soc. Jpn. 69 7 (1996) 1863-1868
26. Hikima T., Hanaya T., and Oguni M. Numerical and morphological approach to the mechanism of homogeneous-nucleation-based crystallization in o-terphenyl. J. Non-Cryst. Solids 235-237 (1998) 539-547
27. Hikima T., Hanaya T., and Oguni M. Microscopic observation of a peculiar crystallization in the glass transition region and β-process as potentially controlling the growth rate in triphenylethylene. J. Mol. Struct. 479 2-3 (1999) 245-250
28. Imaizumi H., Nambu N., and Nagai T. Stability and several physical properties of amorphous and crystalline forms of indomethacin. Chem. Pharm. Bull. 28 (1980) 2565-2569
29. Johari G.P., and Goldstein M. Viscous liquids and the glass transition. III. Secondary relaxations in aliphatic alcohols and other nonrigid molecules. J. Chem. Phys. 55 (1971) 4245
30. In: Johari G.P., Goldstein M., and Simba R. (Eds). The glass transition and nature of the glassy state. Ann. New York Acad. Sci. 279 (1976) 117
31. Johari G.P., Kim S., and Shanker R.M. Dielectric studies of molecular motion in amorphous solid and ultraviscous acetoaminphen. J. Pharm. Sci. 94 (2005) 2207-2223
32. Johari G.P., Kim S., and Shanker R.M. Dielectric relaxation and crystallization of ultraviscous melt and glassy states of Aspirin, Ibuprofen, Progesterone, and Quinidine. J. Pharm. Sci. 96 (2007) 1159-1175
33. Kaminski K., Maslanka S., Ziolo J., Paluch M., McGrath K.J., and Roland C.M. Dielectric relaxation of a-tocopherol acetate (Vitamin E). Phys. Rev. E 75 (2007) 011903
34. Kaminski, K., Kaminska, E., Adrjanowicz, K., Grzybowiska, K., Wlodarczyk, P., Paluch, M., Burian, A., Ziolo, J., Lepek, P., Mazgalski, J., Sawicki, W., 2009. Dielectric relaxation studies on tramadol and its hydrochloride salt, J. Pharm. Sci., doi:10.1002/jps.21799.
35. Kauzmann W. The nature of the glassy state and the behavior of liquids at low temperatures. Chem. Rev. 43 2 (1948) 219-256
36. Kohlrausch R. Nachtrag über die elastiche Nachwirkung beim Cocon und Glasladen. Ann. Phys. (Leipzig) 72 (1847) 393
37. In: Kremers F., and Schonhals A. (Eds). Broadband Dielectric Spectroscopy (2003), Springer, Berlin
38. Kudlik A., Tschirwitz C., Benkhof S., Blochowicz T., and Rössler E. Slow secondary relaxation process in supercooled liquids. Europhys. Lett. 40 (1997) 649
39. Lipinski C. Poor aqueous solubility-an industry wide problem in drug delivery. Am. Pharm. Rev. 5 (2002) 82-85
40. Makower B., and Dye W.B. Equilibrium moisture content and crystallization of amorphous sucrose and glucose. Agric. Food Chem. 4 (1956) 72-77
41. Martino P., Palmieri G.F., and Martelli S. Molecular mobility of paracetamol amorphous form. Chem. Pharm. Bull. 48 8 (2008) 1105-1108
42. Ngai K.L. An extended coupling model description of the evolution of dynamics with time in supercooled liquids and ionic conductors. J. Phys. Condens. Matter 15 (2003) S1107
43. g of glass formers. Phys. Rev. E 69 (2004) 031501
44. Ngai K.L., and Paluch M. Classification of secondary relaxation in glass-formers based on dynamic properties. J. Chem. Phys. 120 (2004) 857
45. Ngai K.L., and Rendell R.W. Supercooled liquids, advances and novel applications. chapter 4, p. 45. In: Fourkas J.T., Kivelson D., Mohanty U., and Nelson K. (Eds). ACS Symposium Series 1997 vol. 676 (1997), American Chemical Society, Washington, DC
46. Ngai K.L., and Tsang K.Y. Similarity of relaxation in supercooled liquids and interacting arrays of oscillators. Phys. Rev. E 60 (1999) 4511-4517
47. Novikov V.N., and Sokolov A.P. Universality of the dynamic crossover in glass-forming liquids: a "magic" relaxation time. Phys. Rev. E 67 (2003) 031507
48. Okamoto N., Oguni M., and Sagawa Y. Generation and extinction of a crystal nucleus below the glass transition temperature. J. Phys. Condens. Matter 9 (1997) 9187
49. g?. Phys. Rev. Lett. 91 (2003) 115701
50. ® HCT, telmisartan and hydrochlorothiazide. Boehringer Ingelheim, Ridgefield, Connecticut. (PI revised 11/2000) reviewed 11/2001.
51. Psurek T., Ziolo J., and Paluch M. Analysis of the decoupling of DC conductivity and structural relaxation time in epoxies with different molecular topology. Physica A 331 (2004) 353-364
52. Purandhar, K., Amarnath Reddy, L., China, M., Kondaiah, G., Santhi Reddy, G., Ramesh Babu, K., 2006. Amorphous Telmisartan, Patent No. US 20060111417 A1.
53. Radtke M. Pure drug nanoparticles for the formulation of poorly soluble drugs. New Drugs 3 (2001) 62-68
54. Rasenack N., and Müller B.W. Poorly water-soluble drugs for oral delivery: a challenge for pharmaceutical development. Part I: Physicochemical and biopharmaceutical background/strategies in pharmaceutical development. Pharmazeutische Industrie 67 3 (2005) 323-326
55. Saleki-Gerhardt A., and Zografi G. Non-isothermal and isothermal crystallization of sucrose from the amorphous state. Pharm. Res. 11 (1994) 1166-1173
56. Schönhals A., Kremer F., Hofmann A., Fischer E.W., and Schlosser E. Anomalies in the scaling of the dielectric α-relaxation. Phys. Rev. Lett. 70 (1993) 3459-3462
57. Shamblin S.L., Hancock B.C., Dupuis Y., and Pikal M.J. Interpretation of relaxation time constants for amorphous pharmaceutical system. J. Pharm. Sci. 89 (1999) 417-427
58. Shamblin S.L., Tang X., Chang L., Hancock B.C., and Pikal M.J. Characterization of the time scale of molecular motion in pharmaceutically important glasses. J. Phys. Chem. B 103 (1999) 4113-4121
59. Stickel F., Fischer E.W., and Richert R. Dynamics of glass-forming liquids. I. Temperature derivative analysis of dielectric relaxation data. J. Chem. Phys. 102 (1995) 6251
60. Stickel F., Fischer E.W., and Richert R. Dynamics of glass-forming liquids. II. Detailed comparison of dielectric relaxation, dc-conductivity, and viscosity data. J. Chem. Phys. 104 (1996) 2043
61. Tammann G., and Hesse W. Die Abhängigkeit der Viscosität von der Temperatur bie unterkühlten Flüssigkeiten. Zeitschrift für anorganische und allgemeine Chemie 156 1 (1926) 245-257
62. Tran P.H.L., Tran H.T.T., and Lee B.J. Modulation of microenvironmental pH and crystallinity of ionizable Telmisartan using alkalizes in solid dispersion for control release. J. Control Rel. 129 (2008) 59-65
63. Vogel H. The law of the relation between the viscosity of liquids and the temperature. Physikalische Zeitschrift 22 (1921) 645-646
64. Wang L.-M., and Richert R. Primary and secondary relaxation time dispersion in fragile supercooled liquids. Phys. Rev. B 76 (2007) 064201
65. Williams G., and Watts D.C. Non-symmetrical dielectric relaxation behavior arising from a simple empirical decay function. Trans. Faraday Soc. 66 (1970) 80-85
66. Yoshioka S., and Aso Y. A quantitative assessment of the significance of molecular mobility as a determinant for the stability of lyophilized insulin formulation. Pharm. Res. 22 (2005) 1358-1364
67. Yoshioka M., Hancock B.C., and Zografi G. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. J. Pharm. Sci. 83 (1994) 1700
68. Yoshioka S., Aso Y., and Miyazaki T. Negligible contribution of molecular mobility to the degradation rate of insulin lyophilized with poly(vinylpyrrolidone). J. Pharm. Sci. 95 (2006) 939-943
69. Zhou D., Zhang G.G.Z., Law D., Grant D.J.W., and Schmitt E.A. Physical stability of amorphous pharmaceuticals: importance of configurational thermodynamic quantities and molecular mobility. J. Pharm. Sci. 91 (2002) 1863-1872
70. Zhou D., Geoff G., Zhang Z., Law D., Grant D., and Schmitt E.A. Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin. Mol. Pharm. 5 6 (2008) 927-936